Peroxisome biogenesis disorders.
暂无分享,去创建一个
H. Moser | A. Moser | G. Raymond | N. Braverman | Ann B Moser | Steven J Steinberg | Hugo W Moser | G. Dodt | Gerald V Raymond | Nancy E Braverman | Gabriele Dodt | S. Steinberg
[1] H. Moser,et al. Plasma and Red Blood Cell Fatty Acids in Peroxisomal Disorders , 1999, Neurochemical Research.
[2] R. Wanders,et al. Alkyl dihydroxyacetone phosphate synthase in human fibroblasts and its deficiency in Zellweger syndrome. , 1985, Journal of lipid research.
[3] R. Wanders,et al. Nonsense and temperature-sensitive mutations in PEX13 are the cause of complementation group H of peroxisome biogenesis disorders. , 1999, Human molecular genetics.
[4] J. Ulrich,et al. Adrenoleukodystrophy. Preliminary report of a connatal case. Light- and electron microscopical, immunohistochemical and biochemical findings. , 1978, Acta neuropathologica.
[5] R. Wanders,et al. A novel aberrant splicing mutation of the PEX16 gene in two patients with Zellweger syndrome. , 2002, Biochemical and biophysical research communications.
[6] P. Lazarow,et al. Targeting of human catalase to peroxisomes is dependent upon a novel COOH-terminal peroxisomal targeting sequence , 1996, The Journal of cell biology.
[7] H. Moser,et al. Mutations in novel peroxin gene PEX26 that cause peroxisome-biogenesis disorders of complementation group 8 provide a genotype-phenotype correlation. , 2003, American journal of human genetics.
[8] R. Wanders,et al. PEX13 is mutated in complementation group 13 of the peroxisome-biogenesis disorders. , 1999, American journal of human genetics.
[9] H. Waterham,et al. Peroxisome biogenesis disorders with prolonged survival: Phenotypic expression in a cohort of 31 patients , 2004, American journal of medical genetics. Part A.
[10] H. Moser,et al. Human PEX7 encodes the peroxisomal PTS2 receptor and is responsible for rhizomelic chondrodysplasia punctata , 1997, Nature Genetics.
[11] R. Wanders,et al. Activity of peroxisomal enzymes and intracellular distribution of catalase in Zellweger syndrome. , 1984, Biochemical and biophysical research communications.
[12] H. Moser,et al. Striated adrenocortical cells in cerebro-hepato-renal (Zellweger) syndrome , 2004, Virchows Archiv A.
[13] H. Waterham,et al. Novel mutations in the PEX12 gene of patients with a peroxisome biogenesis disorder , 2004, European Journal of Human Genetics.
[14] S. Gould,et al. Pex12 Interacts with Pex5 and Pex10 and Acts Downstream of Receptor Docking in Peroxisomal Matrix Protein Import , 1999, The Journal of cell biology.
[15] S. Tamura,et al. The pathogenic peroxin Pex26p recruits the Pex1p–Pex6p AAA ATPase complexes to peroxisomes , 2003, Nature Cell Biology.
[16] H. Nittono,et al. Oral bile Acid treatment in two Japanese patients with Zellweger syndrome. , 2002, Journal of pediatric gastroenterology and nutrition.
[17] J. I. Pedersen,et al. Peroxisomal dysfunction in a boy with neurologic symptoms and amaurosis (Leber disease): clinical and biochemical findings similar to those observed in Zellweger syndrome. , 1986, The Journal of pediatrics.
[18] R. Wanders,et al. Temperature-Sensitive Mutation of PEX6 in Peroxisome Biogenesis Disorders in Complementation Group C (CG-C): Comparative Study of PEX6 and PEX1 , 2000, Pediatric Research.
[19] Kirby D. Smith,et al. Therapeutic developments in peroxisome biogenesis disorders , 2000, Expert opinion on investigational drugs.
[20] D. Crane,et al. Novel PEX1 coding mutations and 5′ UTR regulatory polymorphisms , 2005, Human mutation.
[21] H. Moser,et al. The PEX Gene Screen: molecular diagnosis of peroxisome biogenesis disorders in the Zellweger syndrome spectrum. , 2004, Molecular genetics and metabolism.
[22] A. Moser,et al. Biochemical analysis of cultured chorionic villi for the prenatal diagnosis of peroxisomal disorders: biochemical thresholds and molecular sensitivity for maternal cell contamination detection , 2005, Journal of Medical Genetics.
[23] S. Gould,et al. Identification of a common PEX1 mutation in Zellweger syndrome , 1999, Human mutation.
[24] R. Wanders,et al. Deficiency of acyl-CoA: dihydroxyacetone phosphate acyltransferase in patients with Zellweger (cerebro-hepato-renal) syndrome. , 1984, Biochemical and biophysical research communications.
[25] R. Wanders,et al. Human PEX19: cDNA cloning by functional complementation, mutation analysis in a patient with Zellweger syndrome, and potential role in peroxisomal membrane assembly. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[26] H. Moser,et al. Ether lipid biosynthesis: alkyl-dihydroxyacetonephosphate synthase protein deficiency leads to reduced dihydroxyacetonephosphate acyltransferase activities. , 1999, Journal of lipid research.
[27] P. Mayerhofer,et al. Two splice variants of human PEX19 exhibit distinct functions in peroxisomal assembly. , 2002, Biochemical and biophysical research communications.
[28] R. Wanders,et al. Molecular mechanism of detectable catalase-containing particles, peroxisomes, in fibroblasts from a PEX2-defective patient. , 2000, Biochemical and biophysical research communications.
[29] H. Moser,et al. Mutations in PEX1 are the most common cause of peroxisome biogenesis disorders , 1997, Nature Genetics.
[30] H. Waterham,et al. A PEX6-defective peroxisomal biogenesis disorder with severe phenotype in an infant, versus mild phenotype resembling Usher syndrome in the affected parents. , 2002, American journal of human genetics.
[31] D. Valle,et al. Disorders of peroxisome biogenesis. , 1995, Human molecular genetics.
[32] K. Ghaedi,et al. PEX3 is the causal gene responsible for peroxisome membrane assembly-defective Zellweger syndrome of complementation group G. , 2000, American journal of human genetics.
[33] D. Sillence,et al. Ultrastructure and immunocytochemistry of hepatic peroxisomes in rhizomelic chondrodysplasia punctata , 1992, European Journal of Pediatrics.
[34] H. Waterham,et al. Novel Mutations in the PEX2 Gene of Four Unrelated Patients with a Peroxisome Biogenesis Disorder , 2004, Pediatric Research.
[35] A. Moser,et al. Orthotopic liver transplantation from a living-related donor in an infant with a peroxisome biogenesis defect of the infantile Refsum disease type , 2005, Journal of Inherited Metabolic Disease.
[36] H. Moser,et al. Mutations in the PTS1 receptor gene, PXR1, define complementation group 2 of the peroxisome biogenesis disorders , 1995, Nature Genetics.
[37] H. Waterham,et al. Disorders of peroxisome biogenesis due to mutations in PEX1: phenotypes and PEX1 protein levels. , 2001, American journal of human genetics.
[38] D. Johnson,et al. Unique molecular species of phosphatidylcholine containing very-long-chain (C24-C38) polyenoic fatty acids in rat brain. , 1990, The Biochemical journal.
[39] D. Platt,et al. The biological significance of plasmalogens in defense against oxidative damage , 1998, Experimental Gerontology.
[40] D. Crane,et al. A common PEX1 frameshift mutation in patients with disorders of peroxisome biogenesis correlates with the severe Zellweger syndrome phenotype , 1999, Human Genetics.
[41] M. Noetzel. Fish oil and myelin , 1998, Neurology.
[42] M. Baumgartner,et al. Mutations in antiquitin in individuals with pyridoxine-dependent seizures , 2006, Nature Medicine.
[43] Y Fujiki,et al. Phenotype-genotype relationships in peroxisome biogenesis disorders of PEX1-defective complementation group 1 are defined by Pex1p-Pex6p interaction. , 2001, The Biochemical journal.
[44] Ann Moser,et al. Mutations in the Peroxin Pex26p Responsible for Peroxisome Biogenesis Disorders of Complementation Group 8 Impair Its Stability, Peroxisomal Localization, and Interaction with the Pex1p·Pex6p Complex* , 2006, Journal of Biological Chemistry.
[45] A. Das,et al. Dietary ether lipid incorporation into tissue plasmalogens of humans and rodents , 1992, Lipids.
[46] S. Denis,et al. Major hyperpipecolataemia in a normal adult , 1996, Journal of Inherited Metabolic Disease.
[47] R. Pauli,et al. Natural history of rhizomelic chondrodysplasia punctata , 2003, American journal of medical genetics. Part A.
[48] P. K. Chakraborty,et al. Mutation analysis of PEX7 in 60 probands with rhizomelic chondrodysplasia punctata and functional correlations of genotype with phenotype , 2002, Human mutation.
[49] W. Kearns,et al. Preimplantation Genetic Diagnosis and Screening , 2005, Seminars in reproductive medicine.
[50] H. Moser,et al. PEX7 gene structure, alternative transcripts, and evidence for a founder haplotype for the frequent RCDP allele, L292ter. , 2000, Genomics.
[51] V. Caviness,et al. The mechanism of arrest of neuronal migration in the Zellweger malformation: An hypothesis based upon cytoarchitectonic analysis , 1978, Acta Neuropathologica.
[52] Hugo Moser,et al. Combined liquid chromatography-tandem mass spectrometry as an analytical method for high throughput screening for X-linked adrenoleukodystrophy and other peroxisomal disorders: preliminary findings. , 2006, Molecular genetics and metabolism.
[53] A. Moser,et al. Pharmacological induction of peroxisomes in peroxisome biogenesis disorders , 2000, Annals of neurology.
[54] A. Moser,et al. Phenotype of patients with peroxisomal disorders subdivided into sixteen complementation groups. , 1995, The Journal of pediatrics.
[55] Terje Svingen,et al. Novel PEX1 mutations and genotype–phenotype correlations in Australasian peroxisome biogenesis disorder patients , 2002, Human mutation.
[56] W. Kleijer,et al. Disturbed very long chain (C24–C26) fatty acid pattern in fibroblasts of patients with Zellweger's syndrome , 1985, Journal of Inherited Metabolic Disease.
[57] S. Gould,et al. Phenotype‐genotype relationships in PEX10‐deficient peroxisome biogenesis disorder patients , 2000 .
[58] R. Wanders,et al. Stability of Alkyl‐Dihydroxyacetonephosphate Synthase in Human Control and Peroxisomal Disorder Fibroblasts , 1999, IUBMB life.
[59] H. Moser,et al. Identification of PEX10, the gene defective in complementation group 7 of the peroxisome-biogenesis disorders. , 1998, American journal of human genetics.
[60] É. Vázquez,et al. MRI evidence that docosahexaenoic acid ethyl ester improves myelination in generalized peroxisomal disorders , 1998, Neurology.
[61] H. Moser,et al. Isolation of the human PEX12 gene, mutated in group 3 of the peroxisome biogenesis disorders , 1997, Nature Genetics.
[62] H. Moser,et al. The prenatal diagnosis of the cerebro‐hepato‐renal syndrome of Zellweger , 1985, Prenatal diagnosis.
[63] M. Durán,et al. MRI of the brain and cervical spinal cord in rhizomelic chondrodysplasia punctata , 2006, Neurology.
[64] T. Imanaka,et al. Temperature-sensitive phenotypes of peroxisome-assembly processes represent the milder forms of human peroxisome-biogenesis disorders. , 1998, American journal of human genetics.
[65] J. Gärtner,et al. Genomic organization and characterization of human PEX2 encoding a 35-kDa peroxisomal membrane protein. , 2000, Biochemical and biophysical research communications.
[66] M. D. Lloyd,et al. Refsum's disease: a peroxisomal disorder affecting phytanic acid α‐oxidation , 2002 .
[67] A. Wierzbicki. Clinical significance of oxidation from phytol to phytanic acid in man. , 2004, Molecular genetics and metabolism.
[68] H. Moser,et al. The cerebrohepatorenal (Zellweger) syndrome. Increased levels and impaired degradation of very-long-chain fatty acids and their use in prenatal diagnosis. , 1984, The New England journal of medicine.
[69] K. Ghaedi,et al. The Mammalian Peroxin Pex5pL, the Longer Isoform of the Mobile Peroxisome Targeting Signal (PTS) Type 1 Transporter, Translocates the Pex7p·PTS2 Protein Complex into Peroxisomes via Its Initial Docking Site, Pex14p* , 2000, The Journal of Biological Chemistry.
[70] M. Haust,et al. Hyperpipecolatemia: A new metabolic disorder associated with neuropathy and hepatomegaly: A case study. , 1968, Canadian Medical Association journal.
[71] N. Shimozawa,et al. Genetic heterogeneity of peroxisome biogenesis disorders among Japanese patients: Evidence for a founder haplotype for the most common PEX10 gene mutation , 2003, American journal of medical genetics. Part A.
[72] D. Crane,et al. Oxidation of pristanic acid in fibroblasts and its application to the diagnosis of peroxisomal beta-oxidation defects. , 1996, The Journal of clinical investigation.
[73] R. Wanders,et al. Identification of a new complementation group of the peroxisome biogenesis disorders and PEX14 as the mutated gene , 2004, Human mutation.
[74] S. Ferdinandusse,et al. Reinvestigation of trihydroxycholestanoic acidemia reveals a peroxisome biogenesis disorder , 2004, Neurology.
[75] H. Moser,et al. Fatty alcohol accumulation in the autosomal recessive form of rhizomelic chondrodysplasia punctata. , 1993, Biochemical medicine and metabolic biology.
[76] J. Gärtner,et al. Genetic and clinical aspects of Zellweger spectrum patients with PEX1 mutations , 2005, Journal of Medical Genetics.
[77] A. Moser,et al. Biochemical abnormalities in rhizomelic chondrodysplasia punctata. , 1988, The Journal of pediatrics.
[78] D. Crane,et al. PEX1 mutations in the Zellweger spectrum of the peroxisome biogenesis disorders , 2005, Human mutation.
[79] J. Fryns,et al. Prenatal ultrasound diagnosis of rhizomelic chondrodysplasia punctata in a primigravida , 1994, Prenatal diagnosis.
[80] R. Wanders,et al. A new type of peroxisomal disorder with variable expression in liver and fibroblasts. , 1994, The Journal of pediatrics.
[81] P. Mayerhofer,et al. Defective peroxisome membrane synthesis due to mutations in human PEX3 causes Zellweger syndrome, complementation group G. , 2000, American journal of human genetics.
[82] H. J. Brink,et al. Rapid and quantitative analysis of unconjugated C(27) bile acids in plasma and blood samples by tandem mass spectrometry. , 2001, Journal of lipid research.
[83] R. Wanders,et al. PEX1 deficiency presenting as Leber congenital amaurosis. , 2004, Pediatric neurology.
[84] N. Braverman,et al. Cervical stenosis secondary to rhizomelic chondrodysplasia punctata. , 2001, American journal of medical genetics.
[85] P. Borst,et al. Severe plasmalogen deficiency in tissues of infants without peroxisomes (Zellweger syndrome) , 1983, Nature.
[86] H. Waterham,et al. Identification of the molecular defect in patients with peroxisomal mosaicism using a novel method involving culturing of cells at 40°C: Implications for other inborn errors of metabolism , 2004, Human mutation.
[87] H. Moser,et al. Increased very long chain fatty acids in patients on a ketogenic diet: a cause of diagnostic confusion. , 1993, The Journal of pediatrics.
[88] M. Skoneczny,et al. Rhizomelic chondrodysplasia punctata is caused by deficiency of human PEX7, a homologue of the yeast PTS2 receptor , 1997, Nature Genetics.
[89] D. Danks,et al. Cerebro-hepato-renal syndrome of Zellweger. A report of eight cases with comments upon the incidence, the liver lesion, and a fault in pipecolic acid metabolism. , 1975, The Journal of pediatrics.
[90] H. Moser,et al. Structural and Chemical Alterations in the Cerebral Maldevelopment of Fetal Cerebro‐Hepato-Renal (Zellweger) Syndrome , 1989, Journal of neuropathology and experimental neurology.
[91] P. Beaune,et al. Infantile phytanic acid storage disease, a possible variant of Refsum's disease: Three cases, including ultrastructural studies of the liver , 1982, Journal of Inherited Metabolic Disease.
[92] I. Björkhem,et al. Simple diagnosis of the Zellweger syndrome by gas-liquid chromatography of dimethylacetals. , 1986, Journal of lipid research.
[93] T. Tsukamoto,et al. A human gene responsible for Zellweger syndrome that affects peroxisome assembly. , 1992, Science.
[94] R. Wanders,et al. High incidence of hyperoxaluria in generalized peroxisomal disorders. , 2006, Molecular genetics and metabolism.
[95] H. Moser,et al. Genomic structure and identification of 11 novel mutations of the PEX6 (peroxisome assembly factor‐2) gene in patients with peroxisome biogenesis disorders , 1999, Human mutation.
[96] M. Durán,et al. Short Report: Plasma pipecolic acid is frequently elevated in non-peroxisomal disease , 2003, Journal of Inherited Metabolic Disease.
[97] A. Beyer,et al. Human PEX1 is mutated in complementation group 1 of the peroxisome biogenesis disorders , 1997, Nature Genetics.
[98] K. Setchell,et al. Oral bile acid treatment and the patient with zellweger syndrome , 1992, Hepatology.
[99] C. Chang,et al. Phenotype-genotype relationships in complementation group 3 of the peroxisome-biogenesis disorders. , 1998, American journal of human genetics.
[100] H. Moser,et al. Diagnosis and Follow-Up of a Case of Peroxisomal Disorder With Peroxisomal Mosaicism , 1999, Journal of child neurology.
[101] H. Moser,et al. Peroxisomal ghosts are intracellular structures distinct from lysosomal compartments in Zellweger Syndrome: A confocal laser scanning microscopy study , 2000, Biology of the cell.
[102] P. Rehling,et al. Domain Mapping of Human PEX5 Reveals Functional and Structural Similarities to Saccharomyces cerevisiae Pex18p and Pex21p* , 2001, The Journal of Biological Chemistry.
[103] H. Tabak,et al. Mutational spectrum in the PEX7 gene and functional analysis of mutant alleles in 78 patients with rhizomelic chondrodysplasia punctata type 1. , 2002, American journal of human genetics.
[104] H. Tabak,et al. Rhizomelic chondrodysplasia punctata is a peroxisomal protein targeting disease caused by a non-functional PTS2 receptor , 1997, Nature Genetics.
[105] D. Hansell,et al. Skeletal abnormalities in Refsum's disease (heredopathia atactica polyneuritiformis). , 1990, The British journal of radiology.
[106] R. Wanders,et al. Peroxisomal disorders I: biochemistry and genetics of peroxisome biogenesis disorders , 2004, Clinical genetics.
[107] S. Ferdinandusse,et al. Peroxisomal fatty acid alpha- and beta-oxidation in health and disease: new insights. , 2003, Advances in experimental medicine and biology.
[108] D. Johnson,et al. The occurrence of polyenoic very long chain fatty acids with greater than 32 carbon atoms in molecular species of phosphatidylcholine in normal and peroxisome-deficient (Zellweger's syndrome) brain. , 1988, The Biochemical journal.
[109] D. Valle,et al. An isoform of pex5p, the human PTS1 receptor, is required for the import of PTS2 proteins into peroxisomes. , 1998, Human molecular genetics.
[110] R. Wanders,et al. UvA-DARE ( Digital Academic Repository ) Defective PEX gene products correlate with the protein import , biochemical abnormalities , and phenotypic heterogeneity in peroxisome biogenesis disorders , 1999 .
[111] T. Tsukamoto,et al. A novel mutation, R125X in peroxisome assembly factor‐1 responsible for zellweger syndrome , 1998, Human mutation.
[112] R. G. Holmes,et al. Zellweger syndrome: diagnostic assays, syndrome delineation, and potential therapy. , 1986, American journal of medical genetics.
[113] Y. Kuroki,et al. Human peroxisome assembly factor-2 (PAF-2): a gene responsible for group C peroxisome biogenesis disorder in humans. , 1996, American journal of human genetics.
[114] Jeremy M. Berg,et al. Molecular dynamics simulations of biomolecules , 2002, Nature Structural Biology.
[115] S. South,et al. Peroxisome Synthesis in the Absence of Preexisting Peroxisomes , 1999, The Journal of cell biology.
[116] F. Garzuly,et al. [Cerebro-hepato-renal (Zellweger) syndrome]. , 1974, Orvosi hetilap.
[117] C. Obie,et al. Alternative splicing suggests extended function of PEX26 in peroxisome biogenesis. , 2005, American journal of human genetics.
[118] J. Volpe,et al. Cerebro-hepato-renal syndrome of Zellweger: An inherited disorder of neuronal migration , 2004, Acta Neuropathologica.
[119] M. Baumgartner,et al. Defective peroxisome biogenesis with a neuromuscular disorder resembling Werdnig-Hoffman disease , 1998, Neurology.
[120] A. A. Spector,et al. Docosahexaenoic acid synthesis in human skin fibroblasts involves peroxisomal retroconversion of tetracosahexaenoic acid. , 1995, Journal of lipid research.
[121] H. Waterham,et al. UvA-DARE ( Digital Academic Repository ) Identification of PEX 7 as the second gene involved in Refsum disease , 2003 .
[122] L. Horrocks,et al. Book Review: Plasmalogens: Workhorse Lipids of Membranes in Normal and Injured Neurons and Glia , 2001 .
[123] H. Moser,et al. Identification of three distinct peroxisomal protein import defects in patients with peroxisome biogenesis disorders. , 1995, Journal of cell science.
[124] Y. Suzuki,et al. Mutation in PEX16 is causal in the peroxisome-deficient Zellweger syndrome of complementation group D. , 1998, American journal of human genetics.
[125] Y. Suzuki,et al. Mutations in PEX10 is the cause of Zellweger peroxisome deficiency syndrome of complementation group B. , 1998, Human molecular genetics.
[126] H. Waterham,et al. Biochemical markers predicting survival in peroxisome biogenesis disorders , 2002, Neurology.
[127] I. Rapin,et al. Peroxisomal and Mitochondrial Defects in the Cerebro-Hepato-Renal Syndrome , 1973, Science.
[128] N. Boddaert,et al. Contribution of fetal MR imaging in the prenatal diagnosis of Zellweger syndrome. , 2006, AJNR. American journal of neuroradiology.
[129] T. Tsukamoto,et al. PEX12, the Pathogenic Gene of Group III Zellweger Syndrome: cDNA Cloning by Functional Complementation on a CHO Cell Mutant, Patient Analysis, and Characterization of Pex12p , 1998, Molecular and Cellular Biology.
[130] E. Jellum,et al. Epoxy acids in peroxisomal disorders. , 1986, Scandinavian journal of clinical and laboratory investigation.
[131] H. Bernheimer,et al. The Cerebrohepatorenal (Zellweger) Syndrome: An Improved Method for the Biochemical Diagnosis and its Potential Value for Prenatal Detection , 1985, Pediatric Research.
[132] C. Scriver,et al. The Metabolic and Molecular Bases of Inherited Disease, 8th Edition 2001 , 2001, Journal of Inherited Metabolic Disease.